Enhanced antihypertensive activity of candesartan cilexetil nanosuspension: formulation, characterization and pharmacodynamic study.

Enhanced antihypertensive activity of candesartan cilexetil nanosuspension: formulation, characterization and pharmacodynamic study.

Item
http://www.wikidata.org/entity/Q35185309
Nanotechnology Based Approaches for Enhancing Oral Bioavailability of Poorly Water Soluble Antihypertensive DrugsInvasomes of isradipine for enhanced transdermal delivery against hypertension: formulation, characterization, and in vivo pharmacodynamic study.Transdermal delivery of angiotensin II receptor blockers (ARBs), angiotensin-converting enzyme inhibitors (ACEIs) and others for management of hypertension.Evaluation of Spray BIO-Max DIM-P in Dogs for Oral Bioavailability and in Nu/nu Mice Bearing Orthotopic/Metastatic Lung Tumor Models for Anticancer Activity.Candesartan cilexetil loaded nanodelivery systems for improved oral bioavailability.The effect of polysorbate 20 on solubility and stability of candesartan cilexetil in dissolution mediaDevelopment and characterization of mixed niosomes for oral delivery using candesartan cilexetil as a model poorly water-soluble drug.The effect of PAMAM dendrimer concentration, generation size and surface functional group on the aqueous solubility of candesartan cilexetil.Self-assembled drug delivery system based on low-molecular-weight bis-amide organogelator: synthesis, properties and in vivo evaluation.Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.Fabrication and Characterization of Gliclazide Nanocrystals
P2860

Enhanced antihypertensive activity of candesartan cilexetil nanosuspension: formulation, characterization and pharmacodynamic study.

Item
http://www.wikidata.org/entity/Q35185309
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Enhanced antihypertensive acti ...... ion and pharmacodynamic study.
@ast
Enhanced antihypertensive acti ...... ion and pharmacodynamic study.
@en
type
label
Enhanced antihypertensive acti ...... ion and pharmacodynamic study.
@ast
Enhanced antihypertensive acti ...... ion and pharmacodynamic study.
@en
prefLabel
Enhanced antihypertensive acti ...... ion and pharmacodynamic study.
@ast
Enhanced antihypertensive acti ...... ion and pharmacodynamic study.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Enhanced antihypertensive acti ...... ion and pharmacodynamic study.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932